Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2013 Nov 1;20(2):173–182. doi: 10.1016/j.bbmt.2013.10.022

Figure 6. Distribution of monocyte subpopulations.

Figure 6

Frequencies of CD14++CD16− (a), CD14++CD16+ (b) and CD14+CD16++ monocytes (c) in PBMCs of patients receiving UCB under conventional immunosuppressive treatment developing no GVHD (non-nTreg no GVHD, n=10), patients receiving UCB under conventional immunosuppressive treatment developing GVHD (non-nTreg with GVHD, n=9) or additional nTreg transfer with (nTreg with GVHD, n=6) or without development of GVHD (Treg no GVHD, n=6) at 6 months post-transplant, and of healthy controls (n=10) were determined as described in material and methods. *p≤0.05, **p≤0.01